Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Commission Launches Expert Panel Review Of High-Risk IVDs Despite No EURL Appointments Yet

Executive Summary

Expert panel review of clinical files for high-risk IVDs are happening for the first time under the new EU IVD Regulation.

You may also be interested in...



New MDR And IVDR Implementing Acts Due Imminently

Common specifications, Eudamed arrangements and EU reference laboratories are all topics that should be addressed in EU legislative acts to assist with the implementation of the new medtech regulations.

Expert Panel Review Likely For Just 10% To 20% Of Files Submitted

Expert panel review of clinical files for high-risk devices is happening for the first time under the new EU medtech regulations. The process has begun but expert panel opinions may be rarer than many had originally expected.

First Revision Of EU Medtech Standardization Mandate Due Early 2023

Work is progressing towards publications of an updated list of standards to support implementation of the EU’s new medtech regulations.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT144428

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel